HopeStage
Back to all studies
RecruitingNCT07344948

Safety of NTX-253 in healthy adults and adults with stable schizophrenia

About this titleRead the official source — NCT07344948
Medication studyAges 18–55United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

What will I do during this study?

Adults aged 18 to 55 may be eligible as healthy volunteers or as people with stable schizophrenia. Depending on the study group, participants receive oral NTX-253 or placebo (an inactive comparison treatment) as a single dose or once daily for ten days. Researchers monitor safety, tolerability and how the study drug is processed by the body. This early-phase study is not designed to establish whether NTX-253 treats schizophrenia.

Listed locations
Los AlamitosSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 3, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
73
Sponsor
Neurosterix
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT07344948
Official title
Show the full official title

A First in Human, Phase 1/1b Study of Single and Multiple Ascending Dosing Administration of NTX110253 in Healthy Participants and Participants With Stable Schizophrenia

Recruitment & locations

Currently recruiting

Los Alamitos

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Neurosterix.

Does this study involve medication?

Yes. The study involves medication, including NTX-253 and Placebo.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies